alanylalanine and glycidyl nitrate

alanylalanine has been researched along with glycidyl nitrate in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.67)18.7374
1990's6 (40.00)18.2507
2000's2 (13.33)29.6817
2010's6 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Billot-Klein, D; Collatz, E; Gutmann, L; van Heijenoort, J1
de Roubin, MR; Mengin-Lecreulx, D; van Heijenoort, J1
Ayala, J; Derrien, M; Gómez, M; van Heijenoort, J; van Heijenoort, Y1
Pelzer, H; Reuter, W1
Arthur, M; Courvalin, P; Depardieu, F; Dutka-Malen, S; Reynolds, PE1
Chen, Z; Fukuzawa, S; Ge, M; Kahne, D; Kerns, R; Kohler, J; Onishi, HR; Silver, LL; Thompson, C1
Walsh, C1
Kim, SJ; Matsuoka, S; Patti, GJ; Schaefer, J1
Chen, J; Gross, ML; Patti, GJ; Schaefer, J1
Boger, DL; James, RC; Okano, A; Pierce, JG; Xie, J1
Blanot, D; Bostock, J; Chopra, I; Mengin-Lecreulx, D; Patin, D1
Hesketh, AR; Hill, L; Hong, HJ; Kwun, MJ; Novotna, G1
Donald, LJ; Mark, BL; Patel, TR; Reeve, TM; Standing, KG; Stetefeld, J; Thomas, MD; Vadlamani, G; Vocadlo, DJ1
Chang, JD; Foster, EE; Kim, SJ; Yang, H1
Kim, SJ; Schaefer, J; Sharif, S; Singh, M1

Other Studies

15 other study(ies) available for alanylalanine and glycidyl nitrate

ArticleYear
Analysis of peptidoglycan precursors in vancomycin-resistant enterococci.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7

    Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Dipeptides; Drug Resistance, Microbial; Enterococcus; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin

1992
Peptidoglycan biosynthesis in Escherichia coli: variations in the metabolism of alanine and D-alanyl-D-alanine.
    Journal of general microbiology, 1992, Volume: 138 Pt 8

    Topics: Alanine; Chloramphenicol; Cycloserine; Dipeptides; Escherichia coli; Kinetics; Peptidoglycan

1992
Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3.
    Journal of bacteriology, 1992, Volume: 174, Issue:11

    Topics: Bacterial Proteins; Carrier Proteins; Cell Membrane; Dipeptides; Escherichia coli; Glycosylation; Hexosyltransferases; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan; Peptidyl Transferases; Polyisoprenyl Phosphate Monosaccharides; Polyisoprenyl Phosphate Oligosaccharides; Uridine Diphosphate N-Acetylmuramic Acid

1992
Inhibition of peptidoglycan synthesis in ether-permeabilized Escherichia coli cells by structural analogs of D-alanyl-D-alanine.
    Antimicrobial agents and chemotherapy, 1980, Volume: 18, Issue:6

    Topics: Anti-Bacterial Agents; Dipeptides; Escherichia coli; Ethers; Kinetics; Peptidoglycan; Structure-Activity Relationship

1980
Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.
    Molecular microbiology, 1994, Volume: 13, Issue:6

    Topics: Alanine; Amino Acid Sequence; Bacterial Proteins; Base Sequence; Carbon-Oxygen Ligases; Dipeptides; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus faecium; Gene Expression Regulation, Bacterial; Genes, Bacterial; Hydrolysis; Lactates; Ligases; Molecular Sequence Data; Peptidoglycan; Protein Kinases; Pyruvates; Pyruvic Acid; Serine-Type D-Ala-D-Ala Carboxypeptidase; Teicoplanin; Transcription Factors; Vancomycin

1994
Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
    Science (New York, N.Y.), 1999, Apr-16, Volume: 284, Issue:5413

    Topics: Anti-Bacterial Agents; Carbohydrates; Cell Membrane; Dipeptides; Drug Design; Drug Resistance, Microbial; Enterococcus faecalis; Escherichia coli; Glycosylation; Hexosyltransferases; Lipid Metabolism; Microbial Sensitivity Tests; Peptidoglycan; Peptidoglycan Glycosyltransferase; Protein Binding; Protein Precursors; Structure-Activity Relationship; Vancomycin

1999
Deconstructing vancomycin.
    Science (New York, N.Y.), 1999, Apr-16, Volume: 284, Issue:5413

    Topics: Anti-Bacterial Agents; Bacteria; Cell Wall; Dipeptides; Disaccharides; Drug Design; Drug Resistance, Microbial; Escherichia coli; Glycosylation; Hexosyltransferases; Hydrogen Bonding; Peptidoglycan; Peptidoglycan Glycosyltransferase; Structure-Activity Relationship; Vancomycin

1999
Vancomycin derivative with damaged D-Ala-D-Ala binding cleft binds to cross-linked peptidoglycan in the cell wall of Staphylococcus aureus.
    Biochemistry, 2008, Mar-25, Volume: 47, Issue:12

    Topics: Binding Sites; Cell Wall; Cross-Linking Reagents; Dipeptides; Molecular Conformation; Peptidoglycan; Staphylococcus aureus; Vancomycin

2008
Characterization of structural variations in the peptidoglycan of vancomycin-susceptible Enterococcus faecium: understanding glycopeptide-antibiotic binding sites using mass spectrometry.
    Journal of the American Society for Mass Spectrometry, 2008, Volume: 19, Issue:10

    Topics: Acetylation; Amides; Amines; Binding Sites; Cell Wall; Chromatography, Liquid; Dipeptides; Enterococcus faecium; Glycoside Hydrolases; Hydroxylation; Magnetic Resonance Spectroscopy; Models, Biological; Molecular Structure; Peptides; Peptidoglycan; Succinimides; Tandem Mass Spectrometry; Vancomycin

2008
A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Journal of the American Chemical Society, 2011, Sep-07, Volume: 133, Issue:35

    Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Wall; Dipeptides; Peptidoglycan; Vancomycin; Vancomycin Resistance

2011
Biochemical characterisation of the chlamydial MurF ligase, and possible sequence of the chlamydial peptidoglycan pentapeptide stem.
    Archives of microbiology, 2012, Volume: 194, Issue:6

    Topics: Bacterial Proteins; Chlamydia trachomatis; Dipeptides; Escherichia coli; Genetic Complementation Test; Ligases; Peptidoglycan; Recombinant Proteins; Substrate Specificity; Transformation, Bacterial

2012
In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Dipeptides; Gene Expression Regulation, Bacterial; Ligases; Peptidoglycan; Streptomyces coelicolor; Teicoplanin; Transcription, Genetic; Vancomycin; Vancomycin Resistance

2013
The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide.
    The Journal of biological chemistry, 2015, Jan-30, Volume: 290, Issue:5

    Topics: Bacterial Proteins; beta-Lactamases; Dipeptides; Peptidoglycan; Protein Binding; Scattering, Small Angle; Uridine Diphosphate N-Acetylmuramic Acid

2015
Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
    Biochemistry, 2017, 01-31, Volume: 56, Issue:4

    Topics: Alanine; Anti-Bacterial Agents; Cell Wall; Dipeptides; Endopeptidases; Enterococcus faecalis; Lactates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Peptidoglycan; Uridine Diphosphate N-Acetylmuramic Acid; Vancomycin; Vancomycin Resistance

2017
Desleucyl-Oritavancin with a Damaged d-Ala-d-Ala Binding Site Inhibits the Transpeptidation Step of Cell-Wall Biosynthesis in Whole Cells of Staphylococcus aureus.
    Biochemistry, 2017, 03-14, Volume: 56, Issue:10

    Topics: Anti-Bacterial Agents; Binding Sites; Cell Wall; Dipeptides; Fluorine; Glycopeptides; Isotopes; Lipoglycopeptides; Peptidoglycan; Peptidyl Transferases; Staphylococcus aureus; Vancomycin

2017